Search

See all results

43 Result(s)

Animal Health Innovation

3 tips for anyone interested in a STEM career

Dr. Joanne Maki, veterinary rabies expert, shares what it takes to succeed STEM.

Photo of Sven Sommerlatte, Global Head of HR at Boehringer Ingelheim

Corporate Profile

Career tips from our Global Head of HR

Sven Sommerlatte explains how important it is to reflect on the personal career strategy.

Meet our IT colleagues Natalie, Mounika and Lisa who will change your view of IT

Company Culture

Data science, agile working, UX design: our evolving IT careers

Our IT is constantly evolving, further developing their skills, tools and processes, based on what Boehringer Ingelheim needs today and tomorrow.

Photo of Dr Anna Kaufmann and Dr Achim Sauer

Corporate Profile

Careers: Winning with people

Empowering our employees

BI employee Missy sits at her sofa working on her laptop with a small dog next to her.

Company Culture

Finding purpose in marketing the sciences

Our colleague Missy shares her journey to a career with purpose in Animal Health.

Corporate Profile

One global learning platform for languages, countless opportunities to grow your career

Our Italian colleague Lorenzo learned German via our Global Language Academy

Partnering Culture

The View from Both Sides of the Table

Scott DeWire, US Head of BD&L shares experiences that have taught him first-hand the foundations of successful partnerships

More Health: For People & Animals

Investing in education and knowledge

A supply chain course we sponsored boosted the career of Latifa Saaka

Photo of David Waelder, Chapter Head Agile Coaches for Germany at Boehringer Ingelheim

Corporate Profile

Top Employer: learning and development with an impact

David’s story shows what makes us a Global Top Employer 2024

Three illustrated women working and science before yellow background, animated

More Potential

Passion for science

Discover how our women excelling in STEM careers can improve health equity and create sustainable healthcare solutions.

Michael Sand’s personal perspective on CNS research

Mental Disorders

Our Commitment Never Stops

Meet BI’s Brains: Michael Sand’s personal perspective on CNS research

Pulmonary Fibrosis

Hope for the future of interstitial lung disease (ILD) care

Karen Moor, pulmonologist in training and post-doctoral researcher in interstitial lung diseases (ILDs), shares her advice for aspiring pulmonologists and her hopes for the future of ILD care.

Portrait of Miyuki Ono, with her title as Head of Pulmonary Fibrosis Marketing Japan, and her location showing Tokyo, Japan

Corporate Profile

Miyuki Ono shares about an empathy program designed to provide patients with holistic support

Science & Innovation

“Digital solutions save lives”

Michael Schmelmer explains why digital solutions have a huge impact on Boehringer Ingelheim’s pledge to improve human and animal health.

Women in Science at Boehringer Ingelheim

Our Stories

Be curious, go change the world

Female scientists at Boehringer Ingelheim drive innovation and make medicine happen.

Corporate Profile

Young scientists realize their potential at our company

Three international postdocs explain what they are focusing their research on and why they chose Boehringer Ingelheim.

Photo of scientist Birgit Wilding in the laboratory

Science Stories

Targeting HER2 in cancer: The story of zongertinib

Our cancer researchers share insights into the discovery of zongertinib, our investigational HER2 tyrosine kinase inhibitor.

Lamine Mbow, Global Head of Cancer Immunology and Immune Modulation at Boehringer Ingelheim, shares our approach to Immuno-oncology

Science Stories

T-cell engagers: Reawakening T-cells to fight cancer

Lamine Mbow, our Global Head of Cancer Immunology and Immune Modulation, shares our approach to immuno-oncology, highlighting our T-cell engagers platform and how we are driving innovation to deliver meaningful advances to people with cancer.

Group of scientists from the Chemical Development department at Boehringer Ingelheim gathering in the kilolab facilities, where the first kilogram quantities of the drug substance is manufactured

Science Stories

Targeting MDM2-p53 in cancer: The story of brigimadlin

Our perseverance and passion for science led to the discovery of brigimadlin, our MDM2-p53 antagonist. It is being clinically investigated as a potential treatment for dedifferentiated liposarcoma, a rare cancer with significant unmet needs.